Maternal tenofovir with Vaccination to prevent Vertical Hepatitis B transmission
This study was carried out by Ha T. Nguyen and colleagues to examine the efficiency and safety of pharmaceutical therapies to prevent vertical transmission of the hepatitis B virus.
Cochrane, Medline, and Scopus databases were searched for this study up to October 28th, 2020. All randomized controlled studies that reported vertical hepatitis B viral transmission with the pharmaceutical intervention were properly searched and included in the analysis. The Cochrane Risk-of-Bias tool Version 2 was used to assess the risk of bias. The effectiveness of the treatment was calculated using a stratified network meta-analysis which was based on maternal hepatitis B envelope antigen status.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd